Commercial Physical and Biological Research - Insider Trading Data

Insiders are officers, directors, or significant investors. This page shows insider sentiment and transactions for the Commercial industry. Research shows that insider trades are predictive of future stock returns. By examining insider trades for an industry, we can understand what well-informed people think of the overall future industry prospects.

Commercial Physical and Biological Research - Insider Buy/Sell Ratio

Insider selling and buying is a useful indicator for analyzing the market because it serves as a proxy for their optimism or pessimism in their own companies. By looking at ratio of total selling and buying across the entire market, we might be able to draw some conclusions about the future market.

We offer two charts here. The first one shows the total dollar volume of buying and selling by insiders. The second chart shows the ratio of the number of insiders selling, vs. the number of insiders buying. In both charts, we filter out trades made by indirect holders (such as trusts), and 10% owners (who, although considered an 'insider' by the SEC, do not actually manage the companies in which they are considered insiders).

Corporate Insider Buy Sell Ratio (Dollar Volume) - Commercial Physical and Biological Research
Corporate Insider Buy Sell Ratio (Insider Count) - Commercial Physical and Biological Research
Commercial Physical and Biological Research - Transaction History

Click the link icon to see the full transaction history. Transactions reported as part of a 10b5-1 automatic trading plan will have an X in the column marked 10b-5.

Tran
Date
Security Form Insider Code 10b5-1 Direct Share
Price
Shares
Changed
2026-05-08 CRL / Charles River Laboratories International, Inc. 4 Kemps-Polanco Reshema A - Award D 177.62 1,438
2026-05-08 CRL / Charles River Laboratories International, Inc. 4 FOSTER JAMES C A - Award D 177.62 1,438
2026-05-08 CRL / Charles River Laboratories International, Inc. 4 MACKAY MARTIN A - Award D 177.62 1,438
2026-05-08 CRL / Charles River Laboratories International, Inc. 4 Barg Steven A - Award D 177.62 1,438
2026-05-08 CRL / Charles River Laboratories International, Inc. 4 Kemps-Polanco Reshema A - Award D 177.62 535
2026-05-08 CRL / Charles River Laboratories International, Inc. 4 Enyedy Mark J A - Award D 177.62 1,438
2026-05-08 CRL / Charles River Laboratories International, Inc. 4 FOSTER JAMES C A - Award D 177.62 422
2026-05-08 CRL / Charles River Laboratories International, Inc. 4 Llado George A - Award D 177.62 1,438
2026-05-08 CRL / Charles River Laboratories International, Inc. 4 Andrews Nancy C A - Award D 177.62 1,438
2026-05-08 CRL / Charles River Laboratories International, Inc. 4 Thompson Craig B. A - Award D 177.62 1,438
2026-05-08 CRL / Charles River Laboratories International, Inc. 4 Graves Paul W A - Award D 177.62 1,438
2026-05-08 CRL / Charles River Laboratories International, Inc. 4 MACKAY MARTIN A - Award D 177.62 1,407
2026-05-08 CRL / Charles River Laboratories International, Inc. 4 Llado George A - Award D 177.62 450
2026-05-06 INCY / Incyte Corporation 4/A Stein Steven H A - Award D 44,124
2026-05-06 INCY / Incyte Corporation 4/A CAGNONI PABLO J A - Award D 31,517
2026-05-04 INCY / Incyte Corporation 4 Upadhyay Suketu A - Award D 26,343
2026-05-01 CRL / Charles River Laboratories International, Inc. 4 Coleman Glenn A - Award D 165.78 21,112
2026-04-24 MEDP / Medpace Holdings, Inc. 4 Brady Kevin M. M - Exercise D 138.87 7,000
2026-04-24 MEDP / Medpace Holdings, Inc. 4 EWALD STEPHEN P M - Exercise D 138.87 3,500
2026-04-23 ONMD / OneMedNet Corporation 4 Kosasa Thomas P - Purchase D 0.89 280,898
2026-04-23 IQV / IQVIA Holdings Inc. 4 GOGGINS COLLEEN A A - Award D 1,571
2026-04-23 IQV / IQVIA Holdings Inc. 4 DANHAKL JOHN G By Trust A - Award I 1,571
2026-04-23 IQV / IQVIA Holdings Inc. 4 Burt Carol By Trust A - Award I 1,571
2026-04-23 IQV / IQVIA Holdings Inc. 4 LEONARD JOHN M. A - Award D 1,571
2026-04-21 OABI / OmniAb, Inc. 4 Gotwals Philip J M - Exercise D 13,333
2026-04-21 OABI / OmniAb, Inc. 4 Crouse Steven C. M - Exercise D 13,333
2026-04-17 INCY / Incyte Corporation 4 CAGNONI PABLO J S - Sale D 96.50 -18,667
2026-04-17 INCY / Incyte Corporation 4 CAGNONI PABLO J M - Exercise D 71.93 12,590
2026-04-17 INCY / Incyte Corporation 4 CAGNONI PABLO J M - Exercise D 64.25 6,077
2026-04-15 INCY / Incyte Corporation 4 Meury William M - Exercise D 125,000
2026-04-15 INCY / Incyte Corporation 4 Stein Steven H A - Award D 39,049
2026-04-15 MXCT / MaxCyte, Inc. 4 Ahuja Parmeet A - Award D 187,500
2026-04-15 INCY / Incyte Corporation 4 CAGNONI PABLO J A - Award D 27,892
2026-04-07 OABI / OmniAb, Inc. 4 Berkman Charles S S - Sale D 1.49 -7,157
2026-04-07 OABI / OmniAb, Inc. 4 GUSTAFSON KURT A S - Sale D 1.49 -6,913
2026-04-07 OABI / OmniAb, Inc. 4 FOEHR MATTHEW W S - Sale D 1.49 -19,244
2026-04-07 OABI / OmniAb, Inc. 4 FOEHR MATTHEW W M - Exercise D 36,459
2026-04-07 OABI / OmniAb, Inc. 4 GUSTAFSON KURT A M - Exercise D 13,542
2026-04-07 OABI / OmniAb, Inc. 4 Berkman Charles S M - Exercise D 13,542
2026-04-01 ONMD / OneMedNet Corporation 4 Yu Jeffrey P - Purchase D 0.83 903,614
2026-04-01 ONMD / OneMedNet Corporation 4 Yu Jeffrey A - Award D 0.83 219,429
2026-03-31 MEDP / Medpace Holdings, Inc. 4 Kraft Robert O. M - Exercise D 33
2026-03-31 MEDP / Medpace Holdings, Inc. 4 McCarthy Cornelius P. III M - Exercise D 29
2026-03-31 MEDP / Medpace Holdings, Inc. 4 Carley Brian T M - Exercise D 36
2026-03-31 INCY / Incyte Corporation 4 Clancy Paul J A - Award D 94.12 265
2026-03-31 INCY / Incyte Corporation 4 BAKER BROS. ADVISORS LP See Footnotes A - Award I 421
2026-03-31 INCY / Incyte Corporation 4 BAKER BROS. ADVISORS LP See Footnotes A - Award I 421
2026-03-31 INCY / Incyte Corporation 4 HARRIGAN EDMUND A - Award D 94.12 269
2026-03-27 MXCT / MaxCyte, Inc. 4 Masoud Maher A - Award D 300,000
2026-03-25 INCY / Incyte Corporation 4 Trotta Matteo F - Taxes D 92.23 -537
P
非デリバティブまたはデリバティブ証券の公開市場または非公開購入
S
非デリバティブ証券またはデリバティブ証券の公開市場または非公開売却
A
会社からの有価証券の交付、授与その他の取得 (オプション等)
C
デリバティブの転換
D
有価証券の会社への売却または譲渡
F
会社から受領した有価証券の一部を使用した、行使価格または納税義務のお支払い
G
内部者によるまたは内部者に対する有価証券の贈与
K
株式スワップと類似のヘッジ取引
M
会社から受け取ったデリバティブ証券 (オプションなど) の行使または転換
V
フォーム4により任意に報告した取引
J
その他 (取引を説明する脚注を含む)